5744-59-2Relevant articles and documents
PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS
-
, (2020/05/21)
The disclosures herein relate to novel compounds of formula (1): and salts thereof, wherein A; X;n; R1 and R2 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with H4 receptors.
3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
-
, (2008/06/13)
The object of the invention is heterocyclic compounds of general formula (I) endowed with anticonvulsant activity: STR1 in which Y is selected from --O--, --S-- and STR2 R4 being H or optionally substituted alkyl, acyl or benzyl, Z is selected
Pyrazolodiazepines. 1,3 (and 2,3) dialkyl 4,6 dihydro 8 arylpyrazolo[4,3 e][1,4] diazepin 5 ones as antianxiety agents
DeWald,Nordin,L'Italien,Parcell
, p. 1346 - 1354 (2007/10/04)
A series of 1, 3 (and 2, 3) dialkyl 4, 6 dihydro 8 arylpyrazolo [4, 3 e][1, 4] diazepin 5 ones was synthesized and evaluated for psychotropic activity. Intermediates are new dialkylnitropyrazolyl aryl ketones prepared from dialkylnitropyrazolecarboxylic acids. Many of these pyrazolodiazepines exhibit high CNS activity in animals. One compound, 1 ethyl 4, 6 dihydro 3 methyl 8 phenylpyrazolo [4, 3 e] [1, 4] diazepin 5 (1H) one is about as potent as diazepam as an antianxiety agent with less sedative properties and is being studied in the clinic.